Real-world effectiveness of pembrolizumab for first-line treatment of metastatic non-small-cell lung cancer: a decade of evidence and experience
Future Oncology | July 30, 2026 | Volume: No volume available | Issue: No issue available | Pages: 1-20
10.1080/14796694.2026.2709201